1 paper3 findings
Intra-individual cognitive variability
no changein humans1
Alzheimer's disease biomarkers have no effect on intra-individual cognitive variability in humans.
Humanscognitively intact individuals
Linking cognitive variability and Alzheimer's disease biomarkers by neurocognitive status
Alzheimer's & dementia (Amsterdam, Netherlands)13 Sep 2026
Intra-individual cognitive variability
upin humans1
Alzheimer's disease biomarkers are associated with intra-individual cognitive variability in humans (correlation 0.149 to 0.460).
Humanscognitively impaired individuals
Linking cognitive variability and Alzheimer's disease biomarkers by neurocognitive status
Alzheimer's & dementia (Amsterdam, Netherlands)13 Sep 2026
Menopausal hormone therapy
mixedin reviews1
Menopausal hormone therapy is associated with Alzheimer's disease biomarkers.
“Evidence regarding menopausal hormone therapy (MHT) was mixed; most longitudinal studies and randomized trials reported no clear associations with AD biomarkers”
Reviewfemales
Research Square4 Aug 2026Preprint
National Institute on AgingUS$4.9m
National Institute on AgingUniversity of Pittsburgh at PittsburghUS$804.5k2026–2031
National Institute on AgingUniversity of Pittsburgh at PittsburghUS$125.9k2022–2027
Bridging Gaps to Translate Plasma Alzheimer's Disease Biomarkers to Diverse Populations
National Institute on AgingUniversity of Texas Hlth Science CenterUS$163k2025–2030
Effect of Suvorexant on Alzheimer's Disease Biomarkers
National Institute on AgingWashington UniversityUS$1.5m2023–2029
National Institute on AgingUniversity of ArizonaUS$832.6k2022–2028
National Institute on AgingUniversity of Wisconsin-madisonUS$767.6k2024–2029
Multi-cohort study of factors that influence Alzheimer's disease biomarker and dementia timing
National Institute on AgingUniversity of Wisconsin-madisonUS$770.4k2023–2027
In 64 older adults tracked for 2.6 years, lower rapid eye movement sleep was linked to a faster drop in a blood marker of Alzheimer's disease.In 64 older adults tracked for 2.6 years, lower rapid eye movement sleep was linked to a faster drop in a blood marker of Alzheimer's disease.
In 101 people, the test identified brain amyloid build-up from blood samples with an area under the curve of 0.839, matching established methods.In 101 people, the test identified brain amyloid build-up from blood samples with an area under the curve of 0.839, matching established methods.
Across two aging cohorts spanning normal cognition to mild Alzheimer’s disease, higher education tracked with better cognitive performance even after adjusting for…Across two aging cohorts spanning normal cognition to mild Alzheimer’s disease, higher education tracked with better cognitive performance even after adjusting for multimodal brain pathology.